Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Front Immunol ; 9: 3050, 2018.
Article in English | MEDLINE | ID: mdl-30687308

ABSTRACT

The IRE1α/XBP1s signaling pathway is an arm of the unfolded protein response (UPR) that safeguards the fidelity of the cellular proteome during endoplasmic reticulum (ER) stress, and that has also emerged as a key regulator of dendritic cell (DC) homeostasis. However, in the context of DC activation, the regulation of the IRE1α/XBP1s axis is not fully understood. In this work, we report that cell lysates generated from melanoma cell lines markedly induce XBP1s and certain members of the UPR such as the chaperone BiP in bone marrow derived DCs (BMDCs). Activation of IRE1α endonuclease upon innate recognition of melanoma cell lysates was required for amplification of proinflammatory cytokine production and was necessary for efficient cross-presentation of melanoma-associated antigens without modulating the MHC-II antigen presentation machinery. Altogether, this work provides evidence indicating that ex-vivo activation of the IRE1α/XBP1 pathway in BMDCs enhances CD8+ T cell specific responses against tumor antigens.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , Endoribonucleases/metabolism , Melanoma/immunology , Protein Serine-Threonine Kinases/metabolism , Signal Transduction/immunology , Animals , CD8-Positive T-Lymphocytes/metabolism , Cell Line, Tumor , Cross-Priming/drug effects , Cytokines/immunology , Cytokines/metabolism , Dendritic Cells/drug effects , Dendritic Cells/immunology , Dendritic Cells/metabolism , Endoplasmic Reticulum Stress/immunology , Endoribonucleases/antagonists & inhibitors , Endoribonucleases/genetics , Endoribonucleases/immunology , Humans , Hymecromone/analogs & derivatives , Hymecromone/pharmacology , Lymphocyte Activation/drug effects , Melanoma/pathology , Mice , Mice, Inbred C57BL , Mice, Transgenic , Primary Cell Culture , Protein Serine-Threonine Kinases/antagonists & inhibitors , Protein Serine-Threonine Kinases/genetics , Protein Serine-Threonine Kinases/immunology , Signal Transduction/drug effects , Unfolded Protein Response/immunology , X-Box Binding Protein 1/immunology , X-Box Binding Protein 1/metabolism
2.
PLoS One ; 10(10): e0140672, 2015.
Article in English | MEDLINE | ID: mdl-26474053

ABSTRACT

The aging process is accompanied by altered immune system functioning and an increased risk of infection. Dendritic cells (DCs) are antigen-presenting cells that play a key role in both adaptive and innate immunity, but how aging affects DCs and their influence on immunity has not been thoroughly established. Here we examined the function of conventional DCs (cDCs) in old mice after TLR7 stimulation, focusing on their ability to cross-prime CD8+ T cells. Using polyU, a synthetic ssRNA analog, as TLR7 ligand and OVA as an antigen (Ag) model, we found that cDCs from old mice have a poor ability to stimulate a CD8+ T cell-mediated cytotoxic response. cDCs from old mice exhibit alterations in Ag-processing machinery and TLR7 activation. Remarkably, CD8α+ cDCs from old mice have an impaired ability to activate naïve CD8+ T cells and, moreover, a lower capacity to mature and to process exogenous Ag. Taken together, our results suggest that immunosenescence impacts cDC function, affecting the activation of naïve CD8+ T cells and the generation of effector cytotoxic T cells.


Subject(s)
Aging/immunology , Antigen Presentation , CD8-Positive T-Lymphocytes/enzymology , Cross-Priming/immunology , Dendritic Cells/immunology , Immunity, Cellular , Membrane Glycoproteins/immunology , Toll-Like Receptor 7/immunology , Animals , Antigens/immunology , Antigens/pharmacology , Cross-Priming/drug effects , Female , Mice , Poly U/immunology , Poly U/pharmacology
3.
J Transl Med ; 5: 19, 2007 Apr 20.
Article in English | MEDLINE | ID: mdl-17448240

ABSTRACT

BACKGROUND: In the present study, we demonstrate, in rigorous fashion, that human monocyte-derived immature dendritic cells (DCs) can efficiently cross-present tumor-associated antigens when co-cultured with a mixture of human melanoma cells rendered apoptotic/necrotic by gamma irradiation (Apo-Nec cells). METHODS: We evaluated the phagocytosis of Apo-Nec cells by FACS after PKH26 and PKH67 staining of DCs and Apo-Nec cells at different times of coculture. The kinetics of the process was also followed by electron microscopy. DCs maturation was also studied monitoring the expression of specific markers, migration towards specific chemokines and the ability to cross-present in vitro the native melanoma-associated Ags MelanA/MART-1 and gp100. RESULTS: Apo-Nec cells were efficiently phagocytosed by immature DCs (iDC) (55 +/- 10.5%) at 12 hs of coculture. By 12-24 hs we observed digested Apo-Nec cells inside DCs and large empty vacuoles as part of the cellular processing. Loading with Apo-Nec cells induced DCs maturation to levels achieved using LPS treatment, as measured by: i) the decrease in FITC-Dextran uptake (iDC: 81 +/- 5%; DC/Apo-Nec 33 +/- 12%); ii) the cell surface up-regulation of CD80, CD86, CD83, CCR7, CD40, HLA-I and HLA-II and iii) an increased in vitro migration towards MIP-3beta. DC/Apo-Nec isolated from HLA-A*0201 donors were able to induce >600 pg/ml IFN-gamma secretion of CTL clones specific for MelanA/MART-1 and gp100 Ags after 6 hs and up to 48 hs of coculture, demonstrating efficient cross-presentation of the native Ags. Intracellular IL-12 was detected in DC/Apo-Nec 24 hs post-coculture while IL-10 did not change. CONCLUSION: We conclude that the use of a mixture of four apoptotic/necrotic melanoma cell lines is a suitable source of native melanoma Ags that provides maturation signals for DCs, increases migration to MIP-3beta and allows Ag cross-presentation. This strategy could be exploited for vaccination of melanoma patients.


Subject(s)
Antigens, Neoplasm/immunology , Apoptosis , CD8-Positive T-Lymphocytes/immunology , Cross-Priming/immunology , Dendritic Cells/immunology , Melanoma/pathology , Membrane Glycoproteins/immunology , Neoplasm Proteins/immunology , Apoptosis/drug effects , Apoptosis/radiation effects , CD8-Positive T-Lymphocytes/cytology , CD8-Positive T-Lymphocytes/drug effects , CD8-Positive T-Lymphocytes/radiation effects , Cell Differentiation/drug effects , Cell Differentiation/radiation effects , Cell Line, Tumor , Cell Movement/drug effects , Cell Movement/radiation effects , Chemokine CCL19/pharmacology , Coculture Techniques , Cross-Priming/drug effects , Cross-Priming/radiation effects , Dendritic Cells/cytology , Dendritic Cells/drug effects , Dendritic Cells/ultrastructure , Epitopes/immunology , Gamma Rays , Humans , Interleukin-10/immunology , Interleukin-12/immunology , MART-1 Antigen , Melanoma/immunology , Melanoma/ultrastructure , Monocytes/cytology , Monocytes/immunology , Necrosis , Phagocytosis/drug effects , Phagocytosis/immunology , Phagocytosis/radiation effects , Receptors, CCR7/immunology , Time Factors , gp100 Melanoma Antigen
SELECTION OF CITATIONS
SEARCH DETAIL